Safety and Feasibility Study of Dapivirine (TMC120) Vaginal Ring in Belgium
Double-blind, Randomized, Placebo Controlled Trial to Study Safety, Local and Systemic Availability of TMC120 From a Vaginal Ring.
Sponsor: International Partnership for Microbicides, Inc.
A PHASE1 clinical study on HIV Infections, this trial is completed. The trial is conducted by International Partnership for Microbicides, Inc. and has accumulated 6 data snapshots since 2005. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE1
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE1
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE1
First recorded
Jul 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- International Partnership for Microbicides, Inc.
- Tibotec Pharmaceutical Limited
For direct contact, visit the study record on ClinicalTrials.gov .